Scaling cell & gene therapy operations with Industry 4.0
Sponsor
Live30 webinars are thirty-minute presentations designed to update you on the latest innovations, applications, and data in a fast yet interactive format.
Cell and gene therapies are unlocking a remarkable new landscape of medicine. But the reality is that the science and production are complex and expensive, limiting patient access. Integrating an Industry 4.0 strategy can enable a new trajectory for scaling and navigating this commercial manufacturing process.
Among the challenges are paper-based batch release times being measured in weeks, making it extremely difficult for any facility to manage a reasonable amount of patients without a fully digital solution. The logistics of managing the complete vein-to-vein supply chain is a new challenge for manufacturers that also requires a digital-first approach to scale successfully. Leveraging the connectivity and data from Industry 4.0 solutions alongside innovative process technologies can streamline processes and reduce errors leading to lower operating costs to help close the gap between medicines and patients.
Learn how the CGT industry can apply Industry 4.0 more effectively in a live webinar with experts, Peter Walters, Fellow of Advanced Therapies, and Ryan Thompson, Industry 4.0 Sr. Specialist. Together, Walters and Thompson will look at practical and accessible ways to scale production for personalized medicines with data, digitization, robotics and process closure. This webinar will highlight our industry’s unique challenges, paired with real-world applications that can continue to move us forward.
- Understand the challenges faced by the cell and gene therapy industry in terms of complex and expensive production processes, leading to limited patient access
- Explore the potential benefits and applications of Industry 4.0 strategies, including the integration of data, digitization, robotics, and process closure to streamline production, reduce errors, and lower operating costs
- Analyze practical approaches to identify effective ways for manufacturers to scale production and navigate personalized medicines using Industry 4.0 solutions
SPEAKERS
You might also like
Same-section spatial multiomics: a platform for detailed analysis of the solid tumor TME
Quadplex dPCR as a tool to analyze genome integrity and heterogeneity in gene therapy drug products
Precision in production: optimizing monitoring and quality control for high-value plasmids
Advancing cell therapy: innovations in polymer-based encapsulation and delivery
